BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22965833)

  • 1. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
    Lee J; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
    Kim SH; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
    Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
    Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells.
    Sehrawat A; Sakao K; Singh SV
    Breast Cancer Res Treat; 2014 Aug; 146(3):543-55. PubMed ID: 25038880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
    Hahm ER; Lee J; Huang Y; Singh SV
    Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
    Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
    PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
    Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
    Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
    Stan SD; Hahm ER; Warin R; Singh SV
    Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
    Lee J; Hahm ER; Singh SV
    Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
    Kim SH; Singh SV
    Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.
    Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV
    PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
    Hahm ER; Singh SV
    Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.
    Hahm ER; Lee J; Abella T; Singh SV
    Mol Carcinog; 2019 Nov; 58(11):2139-2148. PubMed ID: 31441116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells.
    Hahm ER; Lee J; Singh SV
    Mol Carcinog; 2014 Nov; 53(11):907-16. PubMed ID: 24019090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
    Kim SH; Singh KB; Hahm ER; Singh SV
    Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics.
    Sehrawat A; Samanta SK; Hahm ER; St Croix C; Watkins S; Singh SV
    Mitochondrion; 2019 Jul; 47():282-293. PubMed ID: 30685490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown.
    Kim SH; Hahm ER; Arlotti JA; Samanta SK; Moura MB; Thorne SH; Shuai Y; Anderson CJ; White AG; Lokshin A; Lee J; Singh SV
    Breast Cancer Res Treat; 2016 May; 157(1):41-54. PubMed ID: 27097807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
    Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
    J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
    Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
    Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.